Development and Qualification of Physiologically Based Pharmacokinetic Models for Drugs With Atypical Distribution Behavior: A Desipramine Case Study
Authors:
Open Access
- 11 April 2017
- journal article
- research article
- Published by Wiley in CPT: Pharmacometrics & Systems Pharmacology
- Vol. 6 (5) , 315-321
Abstract
Desipramine is a secondary tricyclic amine, which is primarily metabolized by cytochrome 2D6. It shows a high volume of distribution (Vss) (10–50 L/kg) due to its high lipophilicity, unspecific phospholipid binding, and lysosomal trapping. The objective of this study was to develop and qualify a physiologically based pharmacokinetic (PBPK) model for desipramine, which accounts for the high Vss of the drug following intravenous and oral administration of doses up to 100 mg. The model also accounts for the extended time to reach maximum concentration after oral dosing due to enterocyte trapping. Once developed and qualified in adults, we characterized the dynamic changes in metabolism and pharmacokinetics of desipramine after birth by scaling the system-specific parameters of the model from adults to pediatrics. The developed modeling strategy provides a prototypical workflow that can also be applied to other drugs with similar properties and a high volume of distribution.Keywords
This publication has 40 references indexed in Scilit:
- Application of Physiologically Based Pharmacokinetic Modeling to Predict Acetaminophen Metabolism and Pharmacokinetics in ChildrenCPT: Pharmacometrics & Systems Pharmacology, 2013
- Development of a Physiologically Based Model for Oseltamivir and Simulation of Pharmacokinetics in Neonates and InfantsClinical Pharmacokinetics, 2011
- Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practicePediatric Anesthesia, 2011
- Cytochrome P450-mediated metabolism in the human gut wallJournal of Pharmacy and Pharmacology, 2009
- Cytochrome P450-mediated metabolism in the human gut wallJournal of Pharmacy and Pharmacology, 2009
- Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling: theophylline and midazolam as model drugsBritish Journal of Clinical Pharmacology, 2004
- Volume of Distribution at Steady State for a Linear Pharmacokinetic System with Peripheral EliminationJournal of Pharmaceutical Sciences, 2004
- Physiologically Based Pharmacokinetic (PBPK) Modeling of Caffeine and Theophylline in Neonates and Adults: Implications for Assessing Children's Risks from Environmental AgentsJournal of Toxicology and Environmental Health, Part A, 2004
- Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorptionAdvanced Drug Delivery Reviews, 1996
- Clinical Pharmacokinetics of Imipramine and DesipramineClinical Pharmacokinetics, 1990